New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
ACR Appropriateness Criteria (R) Ductal Carcinoma in Situ
ACR Appropriateness Criteria (R) Ductal Carcinoma in Situ ONCOLOGY-NEW YORK Kaufman, S. A., Harris, E. E., Bailey, L., Chadha, M., Dutton, S. C., Freedman, G. M., Goyal, S., Halyard, M. Y., Horst, K. C., Novick, K. L., Park, C. C., Suh, W. W., Toppmeyer, D., Zook, J., Haffty, B. G. 2015; 29 (6): 446-?Abstract
Ductal carcinoma in situ (DCIS) is a breast neoplasm with potential for progression to invasive cancer. Management commonly involves excision, radiotherapy, and hormonal therapy. Surgical assessment of regional lymph nodes is rarely indicated except in cases of microinvasion or mastectomy. Radiotherapy is employed for local control in breast conservation, although it may be omitted for select low-risk situations. Several radiotherapy techniques exist beyond standard whole-breast irradiation (ie, partial-breast irradiation [PBI], hypofractionated whole-breast radiation); evidence for these is evolving. We present an update of the American College of Radiology (ACR) Appropriateness Criteria® for the management of DCIS. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions, which are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi technique) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
View details for Web of Science ID 000356842200010
View details for PubMedID 26089220